The Anorexia-Cachexia Syndrome: Pharmacologic Management #515

Daley SF , Ali MA , Ohnuma T , et al. Anorexia and Cachexia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 19, 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430977/ [Last accessed: June 23, 2025].

Roeland EJ , Bohlke K , Baracos VE , et al.; Cancer Cachexia Expert Panel. Cancer Cachexia: ASCO Guideline Rapid Recommendation Update. J Clin Oncol, 2023; 41(25):4178–4179.

Sandhya L , Devi Sreenivasan N , Goenka L , et al. Randomized double-blind placebo-controlled study of olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric, hepatopancreaticobiliary, and lung cancer. J Clin Oncol, 2023; 41(14):2617–2627.

Navari RM , Pywell CM , Le-Rademacher JG , et al. Olanzapine for the Treatment of Advanced Cancer-Related Chronic Nausea and/or Vomiting: A Randomized Pilot Trial. JAMA Oncol, 2020; 6(6):895–899.

Moertel CG , Schutt AJ , Reitemeier RJ , et al. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer, 1974 Jun;33(6):1607–1609.

Bruera E , Roca E , Cedaro L , et al. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep, 1985; 69(7–8):751–754.

Yavuzsen T , Davis MP , Walsh D , et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol, 2005; 23(33):8500–8511.

Beal JE , Olson R , Laubenstein L , et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage, 1995; 10(2):89–97.

Jatoi A , Windschitl HE , Loprinzi CL , et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A North Central Cancer Treatment Group study. J Clin Oncol, 2002; 20(2):567–573.

Loprinzi CL , Schaid DJ , Dose AM , et al. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol, 1993; 11(1):152–154.

Weisberg J , Wanger J , Olson J , et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest, 2002; 121(4):1070–1078.

Ruiz Garcia V , López-Briz E , Carbonell Sanchis R , et al. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev, 2013; 2013(3):Cd004310.

Loprinzi CL , Michalak JC , Schaid DJ , et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol, 1993; 11(4):762–767.

Watanabe N , Omori IM , Nakagawa A , et al. Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev, 2011(12):CD006528.

Laimer M , Kramer-Reinstadler K , Rauchenzauner M , et al. Effect of mirtazapine treatment on body composition and metabolism. J Clin Psychiatry, 2006; 67(3):421–424.

Riechelmann RP , Burman D , Tannock IF , et al. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Am J Hosp Palliat Care, 2010; 27(2):106–110.

Hunter CN , Abdel-Aal HH , Elsherief WA , et al. Mirtazapine in cancer-associated anorexia and cachexia: A double-blind placebo-controlled randomized trial. J Pain Symptom Manage, 2021; 62(6):1207–1215.

Arrieta O , Cárdenas-Fernández D , Rodriguez-Mayoral O , et al. Mirtazapine as appetite stimulant in patients with non-small cell lung cancer and anorexia: A randomized clinical trial. JAMA Oncol, 2024; 10(3):305–314.

Solheim TS , Fearon KC , Blum D , et al. Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review. Acta Oncol, 2013; 52(1):6–17.

Ma YJ , Yu J , Xiao J , et al. The consumption of omega-3 polyunsaturated fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: A systematic evaluation. Nutr Cancer, 2015; 67(1):112–118.

Groarke JD , Crawford J , Collins SM , et al. Ponsegromab for the treatment of cancer cachexia. N Engl J Med, 2024; 391(24):2291–2303.